RecruitingNot ApplicableNCT05335096

An AI-based mHealth Intervention to Improve HIV Testing

Developing an Artificial Intelligence (AI)-Based mHealth Intervention to Improve HIV Testing in Malaysia


Sponsor

Yale University

Enrollment

296 participants

Start Date

Nov 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to develop an artificial intelligence (AI)-chatbot-based mobile health (mHealth) intervention to promote HIV testing in Malaysia.


Eligibility

Sex: MALEMin Age: 18 Years

Inclusion Criteria4

  • Cis-gender male
  • condomless sex with men in the past 6 months
  • HIV status unknown or previously tested negative
  • speaks Bahasa Malaysia or English.

Exclusion Criteria3

  • Does not have a smartphone
  • HIV status previously tested positive
  • cannot speak Bahasa Malaysia or English

Interventions

BEHAVIORALAn AI-chatbot-based mHealth intervention

The participants assigned to the intervention group will get access to an AI-chatbot and can interact with the AI-chatbot at any time. In each round of the interactive communication, the chatbot will provide automated personalized messages containing PrEP, mental health, or HIV testing-related information, motivation and skills based on the participants' answers and will continuously update over time.

BEHAVIORALAn attention-chatbot-based mHealth intervention

The participants assigned to the control group will get access to an attention-chatbot and can interact with the attention-chatbot at any time. In each round of the interaction, the chatbot will provide pre-scripted time-attention health education messages to the participants.

BEHAVIORALEducational materials

the research assistant will manually sent to the participants' phone a piece of educational material and an online survey link every 30 days (at days 30, 60, 90, 120, 150 and 180).


Locations(1)

University of Malaysia

Kuala Lumpur, Malaysia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05335096


Related Trials